Reassessing Surgical Extent in N1b Papillary Thyroid Carcinoma

Abstract

Get full access to this article

View all access options for this article.

References

1. Ringel

, Sosa

, Baloch

, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid 2025;35(8):841-985; doi: 10.1177/10507256251363120.

2. Scholfield

, Boe

, Eagan

, et al. Thyroid lobectomy and neck dissection for N1b papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg 2026;152(2):208-214; doi: 10.1001/jamaoto.2025.4653.

3. Boucai

, Zafereo

, Cabanillas

. Thyroid cancer: a review. JAMA 2024;331(5):425-435; doi: 10.1001/jama.2023.26348.

4. Abiri

, Goshtasbi

, Torabi

, et al. Outcomes and trends of treatments in high-risk differentiated thyroid cancer. Otolaryngol Head Neck Surg 2023;168(4):745-753; doi: 10.1177/01945998221095720.

5. Miyauchi

, Ito

, Fujishima

, et al. Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid 2023;33(7):817-825; doi: 10.1089/thy.2023.0076.

6. Altshuler

, Bikas

, Pappa

, et al. Nonoperative, active surveillance of larger malignant and suspicious thyroid nodules. J Clin Endocrinol Metab 2024;109(8):1996-2002; doi: 10.1210/clinem/dgae082.